NasdaqGM:ATAIPharmaceuticals
Assessing Atai Beckley (NasdaqGM:ATAI) Valuation After NASDAQ Biotechnology Index Inclusion
Atai Beckley (NasdaqGM:ATAI) just earned a spot in the NASDAQ Biotechnology Index, a move that often draws in fresh institutional money as index funds rebalance and passive strategies update their biotech exposure.
See our latest analysis for Atai Beckley.
The inclusion in the NASDAQ Biotechnology Index caps a volatile stretch, with a 30 day share price return of 13.16 percent but a 90 day share price return still down 23.35 percent. At the same time, the year to date share price return of...